Kaiser Permanente denied your step therapy override? Here is what to do next
Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. This guide is specific to Kaiser Permanente appeals.
If Kaiser Permanente denied your step therapy override, you can appeal, and the plan must give you its file and the criteria it used. Filing windows by plan type: at least 180 days (insured and Marketplace plans); at least 180 days (employer self-funded plans); 65 days from the notice (Medicare Advantage); 60 days from the notice (Medicaid managed care). The date printed on your denial notice controls; it can only be later than these floors, never earlier.
Why Kaiser Permanente denies step therapy override
Kaiser Permanente is a vertically integrated system, the insurer (Kaiser Foundation Health Plan), medical groups, and hospitals operate as one closed network. Because the treating physician and the plan share an employer, the appeal pathway looks different from a typical PPO denial: the dispute is often with the in-house utilization-review decision rather than with a separate carrier.
For step therapy override specifically: Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. Federal and many state laws require plans to allow exception requests when the step is clinically inappropriate.
Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
Kaiser Permanente appeals: the rule, the deadline and the next level, by plan type
Which row applies depends on the plan you hold, not on Kaiser Permanente's brand. Your ID card, the Summary Plan Description and the denial letter say which.
| Plan type | Rule that governs | File your appeal within | The plan must answer | If the plan says no again |
|---|---|---|---|---|
| Fully insured employer, individual or Marketplace plan The carrier holds the risk and is licensed in your state. Small employers and almost all individual and HealthCare.gov plans. | 45 CFR 147.136 (Public Health Service Act § 2719), which applies the 29 CFR 2560.503-1 procedures and adds state external review; state insurance law on top. | At least 180 days from the denial (45 CFR 147.136(b); 29 CFR 2560.503-1(h)(3)(i)). | Urgent care: 72 hours. Pre-service: 30 days. Post-service: 60 days. Prior-authorization decisions by Marketplace issuers from 2026: 72 hours expedited, 7 calendar days standard (CMS-0057-F). | External review through your state's process, or the federal process where the state has none, generally within 4 months of the final internal denial (45 CFR 147.136(c), (d)). The state insurance department and its Consumer Assistance Program take complaints. |
| Employer self-funded plan (ERISA) Most large employers. The employer pays the claims and hires the carrier to administer them; the Summary Plan Description says self-funded or self-insured. | ERISA § 503 (29 U.S.C. § 1133) and the claims-procedure rule, 29 CFR 2560.503-1. Federal external review under 45 CFR 147.136(d) for non-grandfathered plans. | At least 180 days from the adverse benefit determination (29 CFR 2560.503-1(h)(3)(i)). | Urgent care: 72 hours. Pre-service: 30 days. Post-service: 60 days (29 CFR 2560.503-1(i)(2)). | Federal external review by an accredited independent review organization, requested within 4 months of the final internal denial (45 CFR 147.136(d)); then a civil action under ERISA § 502(a). State insurance departments do not regulate self-funded plans; the U.S. Department of Labor does. |
| Medicare Advantage (Part C) A private plan that replaces Original Medicare. The card says Medicare Advantage, HMO, PPO or PFFS. | 42 CFR Part 422, Subpart M (§§ 422.560 to 422.634). Coverage decisions must follow Original Medicare rules (42 CFR 422.101). | 65 calendar days from the date on the denial notice to request the plan's reconsideration (42 CFR 422.582, as amended effective 1 January 2025). | Expedited: 72 hours. Standard pre-service: 30 days (7 days for Part B drugs). Payment: 60 days (42 CFR 422.590). | If the plan does not fully reverse itself it must send the case to the Independent Review Entity on its own (42 CFR 422.592); then an ALJ hearing when the amount in controversy meets the annual threshold, the Medicare Appeals Council and federal court. State external review does not apply. |
| Medicaid managed care plan A Medicaid plan run by the carrier under a state contract. The card says Medicaid, Medi-Cal, STAR, HealthChoice or your state's programme name. | 42 CFR Part 438, Subpart F (plan appeals) and 42 CFR Part 431, Subpart E (state fair hearings). | 60 calendar days from the date on the notice of adverse benefit determination to request the plan's appeal (42 CFR 438.402(c)(2)(ii)). State fair hearing: within 120 calendar days of the plan's appeal decision (§ 438.408(f)(2)). | Standard appeal: 30 calendar days. Expedited: 72 hours (42 CFR 438.408(b)). | A state fair hearing after the plan's single level of appeal (§ 438.402(b)); some states add an external medical review. Benefits continue during the appeal if you ask within 10 calendar days of the notice (§ 438.420). |
What you can demand. The plan must give you the claim file, the criteria it applied and any new evidence or rationale before the final decision, free of charge (45 CFR 147.136(b)(2)(ii)(C); 29 CFR 2560.503-1(h)(2)(iii)).
How to open the appeal. Cite 45 CFR 147.136 and 29 CFR 2560.503-1: request the claim file and the criteria, note the decision clocks, and name the state external-review right.
What you can demand. The plan must give you the claim file, the internal rule or criterion it relied on, and the identity of the reviewer, free of charge, on request (29 CFR 2560.503-1(h)(2)(iii), (m)(8)).
How to open the appeal. Cite ERISA § 503 and 29 CFR 2560.503-1 in the opening paragraph: request the claim file and the specific criteria relied on, and note the 30-day (pre-service), 60-day (post-service) and 72-hour (urgent) decision clocks.
What you can demand. The plan may not apply internal criteria that are more restrictive than Medicare's national and local coverage determinations, and must decide medical necessity on your individual circumstances (42 CFR 422.101(b), (c)). You can ask for the case file and the criteria used.
How to open the appeal. Cite 42 CFR 422.582 and 422.101(c): the plan must decide on your individual circumstances under Medicare coverage rules, and must forward an unfavorable reconsideration to the IRE itself.
What you can demand. Free copies of the case file, medical records and the criteria used, before and during the appeal (42 CFR 438.406(b)(5)). Children under 21 have EPSDT rights to medically necessary care (42 U.S.C. 1396d(r)(5)).
How to open the appeal. Cite 42 CFR 438.402 and 438.406(b)(5): request the case file and the criteria, ask for continued benefits within 10 days, and reserve the state fair hearing.
In the CMS Transparency in Coverage data for plan year 2026 (2024 claims), the 3 Kaiser Permanente-family Marketplace issuer filings across 3 states reported in-network claim denial rates from 5.1% to 10.3% (median 7.3%). Issuer-level, self-reported, HealthCare.gov plans only; a denial includes duplicate and administrative denials.
Kaiser Permanente denial rate: every state, three years →Primary sources for this table
- 45 CFR 147.136, internal claims and appeals and external review
- 29 CFR 2560.503-1, ERISA claims procedure
- HealthCare.gov, how to appeal an insurance company decision
- CMS-0057-F, prior-authorization decision timeframes from 2026
- U.S. Department of Labor, EBSA, health benefit claims and appeals
- 42 CFR Part 422, Subpart M, Medicare Advantage grievances, organization determinations and appeals
- 42 CFR 422.101, Medicare Advantage coverage rules and medical-necessity decisions
- Medicare.gov, claims and appeals
- 42 CFR Part 438, Subpart F, Medicaid managed care grievance and appeal system
- 42 CFR Part 431, Subpart E, Medicaid fair hearings
Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.
What Kaiser Permanente denies for step therapy override
The step therapy override services most often denied:
- Biologics for rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis
- MS disease-modifying therapies
- GLP-1s when a less-effective oral is preferred
- Newer migraine therapies (CGRP inhibitors)
- Specialty oncology when older regimens are preferred
Why step therapy override claims get denied
A typical Kaiser Permanente step therapy override denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:
- Patient has not tried and failed the preferred drug
- Documentation of prior trial / failure is incomplete
- Plan does not recognize prior trial done under previous plan
- Contraindication or intolerance not documented in record
The Kaiser Permanente appeal process
Appeal levels: Internal grievance / appeal, then state external review (e.g. DMHC IMR in California). Medicare Advantage follows the federal 5-level ladder: plan → IRE (MAXIMUS) → ALJ → Council → federal court.
Carrier timing: 180 days from denial for internal appeal in most commercial plans; 65 days from the notice for Medicare Advantage reconsideration (42 CFR 422.582). Expedited urgent decisions within 72 hours.
Step therapy timing: Standard exception: typically 72 hours. Expedited urgent: 24 hours. Most state step-therapy override laws require response within 72 hours or less.
What we know about Kaiser Permanente: We coordinate Kaiser appeals through the member-services grievance system while preserving the IMR / external-review pathway. Documenting the closed-network constraint is often the unlock on out-of-plan-referral cases.
Common Kaiser Permanente denial patterns for step therapy override
- Internal grievance before external review. Kaiser members file a grievance with Member Services first. In California, Kaiser's largest market, DMHC oversight applies, and the IMR (Independent Medical Review) pathway opens after Kaiser's final internal decision. Members in other states route to their state DOI or to an IRO.
- Out-of-network referral denials. Because Kaiser is closed-network, most non-emergent out-of-plan care must be authorized in advance. Denials are common when a member seeks a specialist outside the system; the strongest appeal lane is a clinical-necessity argument that the in-network alternative is unavailable or inadequate.
- Medicare Advantage escalates to MAXIMUS. Kaiser's Senior Advantage plans follow the federal 5-level Medicare Advantage ladder. After Kaiser's plan-level reconsideration, the case goes to MAXIMUS Federal Services (the IRE), an external escalation that frequently reverses plan denials when the clinical record is complete.
How to win your Kaiser Permanente step therapy override appeal
Strategy for step therapy override: File a step-therapy override request citing one of the standard override grounds: (1) prior trial and failure of the preferred drug, (2) contraindication to the preferred drug, (3) intolerance / adverse reaction, (4) likely-ineffective based on clinical characteristics, or (5) stability on current therapy. Attach prior pharmacy records from any plan to demonstrate prior trials. Many state laws now codify a tight response timeline for step-therapy overrides, cite the applicable statute.
Filed against Kaiser Permanente, that strategy rides on this procedural spine:
- Procedural-rights anchor. Cite 45 CFR 147.136 and 29 CFR 2560.503-1: request the claim file and the criteria, note the decision clocks, and name the state external-review right. If your Kaiser Permanente coverage is a different plan type (Employer self-funded plan, Medicare Advantage, Medicaid managed care plan), use that row of the table above instead; the rule and the deadline change with the plan, not the carrier.
- Criteria-disclosure demand. Kaiser Permanente frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
- Controlling-standard citation. Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
- Treating-provider attestation. A letter from the treating physician addressing each criterion in Kaiser Permanente's own policy language. This is the single strongest evidentiary element.
- Requested action. A specific demand to reverse the step therapy override denial and approve the service, not a general "please reconsider."
Documents you'll need for your Kaiser Permanente step therapy override appeal
- Denial letter
- Prescription record from current and prior plans
- Prescriber's letter documenting clinical rationale and any prior trials
- Documentation of contraindication or intolerance (if applicable)
- Relevant lab values or imaging supporting indication
What a step therapy override appeal can recover
Typical recovery for step therapy override cases runs $500 - $30,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.
Kaiser Permanente step therapy override appeals: frequently asked questions
Can I get your Kaiser Permanente step therapy requirement waived?
Yes, through a step-therapy override request. Federal and many state laws require plans to grant an exception when the required first-line drug is clinically inappropriate for you.
What are the grounds for a step-therapy override?
Prior trial and failure of the preferred drug, a contraindication to it, an intolerance or adverse reaction, a clinical likelihood that it will be ineffective, or current stability on the prescribed therapy. Any one is sufficient.
How fast must Kaiser Permanente respond to an override request?
A standard exception is typically decided within 72 hours and an urgent one within 24 hours. Many state step-therapy laws codify a 72-hour-or-less response requirement.
What if my prior drug trial was under a different plan?
Bring it anyway. Pharmacy records from any prior plan can document a prior trial and failure; plans sometimes refuse to recognize outside trials, but the records are strong evidence on appeal.
What Apellica does for Kaiser Permanente step therapy override appeals
We file appeals against Kaiser Permanente specifically configured to its internal review process. Every step therapy override appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.
Cost: $0 upfront. We work on contingency for Kaiser Permanente appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.
Start your Kaiser Permanente step therapy override appeal
Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.
Start free appeal review →Questions people ask next
- Step therapy denied my drug. Can I appeal?
- My drug was denied as a formulary exclusion. How do I get an exception?
- How do I request my claim file from my insurer?
What to read next
- Step Therapy ('Fail First'): How to Get an Override — the full guide to this kind of denial, for any insurer
- Step therapy override appeal letter template — free, fill in your own details
- How step therapy override denials are appealed
- How long you have to appeal a Kaiser denial
- Work out your own appeal deadline
Related Kaiser Permanente guides
- Kaiser Permanente surgery denials appeal guide
- Kaiser Permanente mri and imaging denials appeal guide
- Kaiser Permanente medication and prescription denials appeal guide
- Kaiser Permanente medicare denials appeal guide